PTC Therapeutics Inc (PTCT)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
$5.36B
EV to revenue ratio (TTM)
3.41
EV to ebitda
22.59
Financial Performance
Revenue (TTM)
$1.16B
Gross profit (TTM)
$0.64B
EBITDA
$0.31B
Profitability
Operating margin (TTM)
38.00%
Profit margin
-9.17%
Return on assets (TTM)
5.31%
Return on equity (TTM)
-7,740.00%
Per Share Metrics
Revenue per share (TTM)
$13.96
EPS
-$1.47
Diluted EPS (TTM)
-$1.47
Book value
-$2.29
Dividend per share
n/a
Dividend yield
n/a
Valuation Multiples
P/E ratio
n/a
Trailing P/E
n/a
Forward P/E
19.46
PEG ratio
0.81
Price to sales ratio (TTM)
4.64
Price to book ratio (TTM)
1,743.27
Growth
Quarterly earnings growth (YoY)
69.60%
Quarterly revenue growth (YoY)
<0.01%
Analyst Sentiment
Strong buy
4
Buy
9
Hold
2
Sell
0
Strong sell
0
Risk & Volatility
Beta
0.51